doi: 10.1093/HUMREP/DEAE108.041 91 CestaCERotemRBatemanBTChodickGCohenJMFuruKet al
Switching back to mammalian models (hamster, rats, pigs), researchers found that GLP-1 could stimulate insulin secretion and inhibit glucagon release, which could vastly benefit diabetic patients
Therefore, we conclude that 5FU promotes metabolic reprogramming in drug-tolerant cells, increasing mitochondrial activity supported by an acute increase in metabolic gene transcription
For a more comprehensive look at how oral GLP-1 receptor agonists fit into a holistic approach to diabetes management, check out: Understanding GLP-1 Receptor Agonists
By how far it spreads and what comes with it
Reduction in Food Noise In appetite-focused studies (Diabetes, Obesity and Metabolism